Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • Patanjali eyes Rs 1...

    Patanjali eyes Rs 1 lakh-crore turnover in next 5 years

    Written by Ruby Khatun Khatun Published On 14 May 2017 5:29 AM  |  Updated On 14 May 2017 5:29 AM
    Patanjali eyes Rs 1 lakh-crore turnover in next 5 years
    Ahmedabad: Baba Ramdev-led home-grown FMCG major Patanjali Ayurved, which posted a turnover of Rs 10,561 crore in the last fiscal, is now looking at a 10-fold jump in sales in the next five years.

    "Our turnover was Rs 10,561 crore last (fiscal) year. Now, we are targeting to achieve a turnover of Rs 1 lakh crore in the next five years," said Ramdev at a press conference on Wednesday.

    On the occasion, the yoga guru-cum-entrepreneur announced his company will donate an equal amount of money for various social causes during the next 20 to 25 years.

    "Foreign companies (operating in India) do not give anything for charity, while we donate 100 per cent of our profit for the betterment of the society. We have set a target of giving away Rs 1 lakh crore for charity, including for education, during the next 20 to 25 years," he said.

    Asked about his plans for Gujarat, Ramdev said the Patanjali Yogpeeth may come up with a 'Cow Research Centre' in the state.

    "We are working on a project to increase milk yield of various cow breeds of Gujarat such as Kankreji and Gir. By using various methods and through embryo transplantation, we can increase the yield from 5 litres to almost 50 litres per day," said Ramdev.

    "It is very much possible that we would set up a Cow Research Centre in Gujarat to carry out these activities. However, you have to wait for a formal announcement on June 21," he added.
    561 croreBaba RamdevCow Research Centreembryo transplantationGirKankrejiPatanjaliPatanjali AyurvedPatanjali YogpeethRs 1 lakh croreRs 10targetturnover
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok